Accelerate Patient Journey Insights with Enriched Lab Data

Accelerate your understanding of the patient journey with Prognos' enriched and harmonized lab data. By providing a comprehensive and de-identified view of patient health, we empower life sciences teams to pinpoint critical moments in disease and treatment progression. This allows you to rapidly align brand strategies with real-world clinical decisions.

Empower Patient Journey Analysis

Our enriched lab data provides the foundational information you need to:

  • Define patient cohorts
    Identify and analyze specific patient populations based on detailed lab results and disease progression markers.

  • Map treatment pathways
    Understand treatment patterns and the progression of disease, from initial diagnosis to subsequent lines of therapy.

  • Measure time-to-event
    Calculate the duration between key clinical events, such as diagnosis and treatment initiation, to better understand patient care timelines.

Real-World Impact:
The Multiple Myeloma Patient Journey

Your brand's success relies on understanding the intricate path a patient takes from symptoms to diagnosis and treatment. Our data provides the detailed lab results needed to map this journey with precision. For example, in Multiple Myeloma (MMY), our enriched lab data can help you:

  • Identify when specific diagnostic tests, like serum protein electrophoresis (SPEP) or free light chain assays, are ordered.

  • Track changes in biomarker levels that indicate disease progression or response to treatment.

  • Correlate treatment decisions with lab results to understand 
how physicians are managing the disease in real time.

Patient Journey Multiple Myeloma Patient with an M-protein Spike

Lab testing tells you why there was a treatment change

patient-journey
Text-Only Version